Professor, Department of Internal Medicine, Associate Provost for Research and Vice President, Rush University, Chicago, IL.
CA Cancer J Clin. 2014 Sep-Oct;64(5):352-63. doi: 10.3322/caac.21239. Epub 2014 Jun 27.
After a comprehensive review of the evidence, the United States Preventive Services Task Force recently endorsed screening with low-dose computed tomography as an early detection approach that has the potential to significantly reduce deaths due to lung cancer. Prudent implementation of lung cancer screening as a high-quality preventive health service is a complex challenge. The clinical evaluation and management of high-risk cohorts in the absence of symptoms mandates an approach that differs significantly from that of symptom-detected lung cancer. As with other cancer screenings, it is essential to provide to informed at-risk individuals a safe, high-quality, cost-effective, and accessible service. In this review, the components of a successful screening program are discussed as we begin to disseminate lung cancer screening as a national resource to improve outcomes with this lethal cancer. This information about lung cancer screening will assist clinicians with communications about the potential benefits and harms of this service for high-risk individuals considering participation in the screening process.
在美国预防服务工作组对证据进行全面审查后,最近认可了使用低剂量计算机断层扫描进行筛查的方法,这种方法有可能显著降低肺癌导致的死亡。谨慎地将肺癌筛查作为一项高质量的预防保健服务实施是一个复杂的挑战。在没有症状的情况下,对高危人群进行临床评估和管理需要采用与症状性肺癌显著不同的方法。与其他癌症筛查一样,为有风险的个人提供知情选择、安全、高质量、具有成本效益且易于获得的服务至关重要。在这篇综述中,我们将讨论成功的筛查计划的组成部分,因为我们开始将肺癌筛查作为一项国家资源来推广,以改善这种致命癌症的治疗效果。这些关于肺癌筛查的信息将帮助临床医生就这项服务对考虑参与筛查过程的高危个人的潜在益处和危害进行沟通。